Vitamin K2 (MK-7) — Research Profile

Vitamin K1 (phylloquinone) is found in green leafy vegetables and primarily supports blood clotting. Vitamin K2 (menaquinone) is found in fermented foods and animal products and primarily supports calcium metabolism — directing calcium into bones and away from arteries ^[2]. They activate different proteins: K1 mainly activates clotting factors in the liver, while K2 activates osteocalcin (bones) and MGP (arteries) throughout the body.

Yes, combining K2 with vitamin D is recommended, especially at higher D3 doses. Vitamin D increases calcium absorption from the gut, and K2 ensures that calcium goes to your bones rather than accumulating in arteries. Without adequate K2, increased calcium absorption from vitamin D could theoretically contribute to arterial calcification. A general guideline is 100 mcg MK-7 per 1,000-2,000 IU vitamin D3.

MK-7 is generally preferred for daily supplementation because of its long half-life (72 hours) allowing once-daily dosing and consistent blood levels. MK-4 has a very short half-life (1-2 hours) requiring multiple doses daily, but has more direct tissue-level research, particularly for bone health at pharmacological doses (45 mg/day) in Japan. For most people, MK-7 at 100-200 mcg daily is the practical choice.

The best form of vitamin k2 (mk-7) depends on your specific health goals, absorption needs, and tolerance. Chelated and standardized extract forms generally offer higher bioavailability than raw or unstandardized versions. Check the product label for third-party testing to ensure potency and purity.

Vitamin K2 (MK-7) has been studied for multiple health applications with varying levels of clinical evidence. The strongest evidence typically comes from randomized controlled trials and meta-analyses published in peer-reviewed journals. Individual responses can vary based on baseline status, dosage, and duration of use.

Vitamin K2 (MK-7) dosage depends on the specific form, your health goals, and individual factors such as body weight and baseline nutrient status. Following the dose used in clinical trials is generally the most evidence-based approach. Starting at the lower end of the recommended range and adjusting upward is advisable.

Vitamin K2 (MK-7) timing depends on whether it is fat-soluble or water-soluble and whether it causes digestive sensitivity. Consistency in timing is more important than the specific hour of the day. Taking supplements at the same time daily helps maintain steady levels.

Vitamin K2 (MK-7) is generally well tolerated at recommended doses, with gastrointestinal discomfort being the most commonly reported side effect. Side effects are typically mild and dose-dependent, resolving with dose reduction or taking with food. Serious adverse effects are rare at standard supplemental doses.

Vitamin K2 (MK-7) may interact with certain prescription medications by affecting absorption, metabolism, or pharmacological effects. Always inform your healthcare provider about all supplements you take, especially before surgery or when starting new medications. Spacing supplements and medications by 2 hours reduces most absorption interactions.

Vitamin K2 (MK-7) is most appropriate for individuals with confirmed deficiency, suboptimal levels, or specific health conditions supported by clinical evidence. People in higher-risk demographics, including older adults and those with restricted diets, may benefit most. Testing baseline levels before supplementing provides the best guidance.

Vitamin K2 (MK-7) effects vary by the specific health outcome being targeted, with some benefits appearing within days and others requiring weeks to months of consistent daily use. Correcting a deficiency typically shows improvement within 2-4 weeks. A minimum 8-12 week trial at the recommended dose is advisable before evaluating effectiveness.

Vitamin K2 (MK-7) is considered safe for long-term use at recommended doses based on available clinical data. Staying within established upper intake limits minimizes the risk of adverse effects over time. Periodic reassessment with a healthcare provider is recommended, especially if health conditions change.

Exceeding the recommended dose of vitamin k2 (mk-7) increases the risk of adverse effects without providing additional benefit. Toxicity risk varies by form and individual factors such as kidney and liver function. Mega-dosing is not supported by clinical evidence and should be avoided.

Vitamin K2 (MK-7) can generally be combined with complementary supplements, though some combinations may affect absorption or create additive effects. Spacing different supplements by 1-2 hours can reduce absorption competition. Consulting a healthcare professional is advisable when combining multiple supplements targeting the same health pathway.

Third-party testing from USP, NSF, or ConsumerLab is the most important quality indicator when purchasing vitamin k2 (mk-7) supplements. Look for products that clearly state the specific form, dose per serving, and any relevant standardization percentages. Avoid proprietary blends that hide individual ingredient amounts.